Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr 4;129(6):2578-2594.
doi: 10.1172/JCI98857.

Macrophage-lineage TRAP+ cells recruit periosteum-derived cells for periosteal osteogenesis and regeneration

Affiliations

Macrophage-lineage TRAP+ cells recruit periosteum-derived cells for periosteal osteogenesis and regeneration

Bo Gao et al. J Clin Invest. .

Abstract

The periosteum, a thin tissue that covers almost the entire bone surface, accounts for more than 80% of human bone mass and is essential for bone regeneration. Its osteogenic and bone regenerative abilities are well studied, but much is unknown about the periosteum. In this study, we found that macrophage-lineage cells recruit periosteum-derived cells (PDCs) for cortical bone formation. Knockout of colony stimulating factor-1 eliminated macrophage-lineage cells and resulted in loss of PDCs with impaired periosteal bone formation. Moreover, macrophage-lineage TRAP+ cells induced transcriptional expression of periostin and recruitment of PDCs to the periosteal surface through secretion of platelet-derived growth factor-BB (PDGF-BB), where the recruited PDCs underwent osteoblast differentiation coupled with type H vessel formation. We also found that subsets of Nestin+ and LepR+ PDCs possess multipotent and self-renewal abilities and contribute to cortical bone formation. Nestin+ PDCs are found primarily during bone development, whereas LepR+ PDCs are essential for bone homeostasis in adult mice. Importantly, conditional knockout of Pdgfrβ (platelet-derived growth factor receptor beta) in LepR+ cells impaired periosteal bone formation and regeneration. These findings uncover the essential role of periosteal macrophage-lineage cells in regulating periosteum homeostasis and regeneration.

Keywords: Bone Biology; Bone development.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors have declared that no conflict of interest exists.

Figures

Figure 1
Figure 1. Nestin+ and LepR+ cells are located in the outer layer of the periosteum.
(AD) Representative images of coronal tibia diaphyseal periosteum sections from 0.5-, 1-, 3-, and 12-month-old male mice stained for TRAP and Nestin (A), TRAP and LepR (B), periostin (C), Emcn and CD31 (D), and representative H&E staining images (E). (FN) Quantification of the periosteal (F), endosteal TRAP+ mononuclear cells (G), periosteal TRAP+ multinuclear cells (H), Nestin+ cells (I and J), LepR+ cells (K and L), periostin+ cells (M), and CD31hiEmcnhi vessels (N) in the inner layer of periosteum (no. cells/P.BS) and/or whole periosteum (no. cells/periosteum) (n = 5 mice/group). (O and P) Quantification of the thickness (O) and cellularity (P) of the inner layer of periosteum. Scale bars: 100 μm (n = 5 mice/group). Dashed lines in AD indicate the limit between the inner layer and outer layer of periosteum and cortical bone. Dashed lines in E indicate the limit between the inner layer and outer layer of periosteum. The double-headed arrows indicate the width of the inner layer of periosteum. Data are presented as mean ± SEM. *P < 0.05; **P < 0.01. C, cortical bone; CL, cambium layer (inner layer) of periosteum; FL, fibrous layer (outer layer) of periosteum; NS, not significant as determined by ANOVA with Bonferroni’s post hoc analysis.
Figure 2
Figure 2. Subsets of periosteal Nestin+ and LepR+ cells possess self-renewal capacity and commit to osteogenic lineage cells.
In vivo serial transplantation of Nestin-GFP+PDGFR-α+ CD45Ter119CD31 (A) and LepR-YFP+CD45Ter119CD31 PDCs (B). Single cell–derived colonies from donors’ PDCs were expanded to generate 5 × 106 cells and injected into the femora of five 1-month-old NOD SCID mice at a density of 1 × 106 per injection. GFP+ or YFP+ cells were sorted from the primary recipients’ bone marrow at 8 weeks after injection and harvested for forming CFU-Fs. The colonies were then transplanted into the secondary recipient mice. FAC analysis of CFU-Fs showed the percentages of GFP+ or YFP+ cells expressing MSC markers (CD90 and CD105) (bottom panels in A and B). (CJ) Lineage-tracing of periosteal Nestin+ cells in Nes-creERT2 R26R-EYFP mice. Samples were collected 2, 7, and 14 days or 2, 14, and 30 days after tamoxifen (100 mg/kg i.p.) administration at P14 or P60, respectively (C, G). Representative images of coronal tibia diaphyseal periosteum sections stained for YFP and Osx (D and H), YFP and CD31 (E and I). Quantification of Nestin+ lineage cells’ contribution to periosteal Osx+ osteoblasts (F and J, left panel), CD31+ endothelial cells (F and J, right panel) (n = 5 mice/group). Representative images from 1- or 3-month-old LepR-cre R26R-EYFP mice stained for YFP and Osx (L), YFP and CD31 (M). Scale bars: 20 μm. (N) Quantification of LepR+ lineage cells’ contribution to periosteal Osx+ osteoblasts (left panel) and CD31+ endothelial cells (right panel). Data are presented as mean ± SEM. *P < 0.05; **P < 0.01. C, periosteal cortical bone; NS, not significant as determined by ANOVA with Bonferroni’s post hoc analysis; P, periosteum.
Figure 3
Figure 3. Deficiency in macrophage-lineage cells impairs cortical bone formation and periosteum homeostasis.
(AC). Upper panels, representative images of coronal tibia diaphyseal periosteum sections from Csf1–/– mice and their control littermates (Csf1+/+) stained for TRAP and Nestin (A), TRAP and LepR (B), and periostin (C). Lower panels, high-power magnification images of the boxed area of the upper panels. (DF) Quantification of TRAP+ mononuclear cells (D), Nestin+ cells and LepR+ cells (E), and periostin+ cells (F) in the inner layer of periosteum (no. cells/P.BS) and/or whole periosteum (no. cells/periosteum) (n = 5 mice/group). Dashed lines in AC indicate the limit between periosteum and cortical bone. Scale bars: 100 μm (upper panels), 20 μm (lower panels). Data are presented as mean ± SEM. *P < 0.05; **P < 0.01. C, periosteal cortical bone; NS, not significant as determined by 2-tailed Student t test; P, periosteum.
Figure 4
Figure 4. Ablation of TRAP+ cells impairs recruitment of PDCs for periosteal bone formation.
(A) Diphtheria toxin treatment in iDTR and Trap-cre iDTR mice. (B) Representative TRAP staining images of coronal trabecular bone (TB) and cortical bone sections. Black arrows indicate TRAP+ cells. Scale bars: 300 μm (n = 5 mice/group). (C) Representative microcomputed tomography (μCT) images. Scale bars: 1 mm (n = 5 mice/group). (DG) Representative images of coronal tibia diaphyseal periosteum sections stained for TRAP and Nestin (D, top), TRAP and LepR (D, middle), periostin (D, bottom), and quantification of the TRAP+ mononuclear cells (E), Nestin+ cells (F), and LepR+ cells (G) in the inner layer of periosteum (no. cells/P.BS) and/or whole periosteum (no. cells/periosteum). (H and I) Percentage of Ki-67+ (H) or Brdu+ (I) cells in Nestin+ or LepR+ cells on periosteum. (J) Quantification of periostin+ cells in the inner layer of periosteum (no. cells/P.BS). Scale bars: 20 μm (n = 5 mice/group). Dashed line in D indicates the line between periosteum and cortical bone. Data are presented as mean ± SEM. *P < 0.05; **P < 0.01. BM, bone marrow; C, cortical bone; NS, not significant as determined by 2-tailed Student t test; P, periosteum.
Figure 5
Figure 5. PDGF-BB secreted by TRAP+ cells recruits PDCs to the periosteal surface for cortical bone formation.
(A) Representative images of coronal tibia diaphyseal periosteum sections from Trap-cre Pdgfbfl/fl mice and Pdgfbfl/fl mice stained for TRAP and Nestin (top) and TRAP and LepR (bottom). (B and C) Quantification of Nestin+ cells (B) and LepR+ cells (C) in the inner layer of periosteum (no. cells/P.BS) and/or whole periosteum (no. cells/periosteum). Scale bars: 20 μm (n = 5 mice/group). (D and E) Percentage of Ki-67+ (D) or Brdu+ (E) cells in Nestin+ or LepR+ cells on periosteum (n = 5 mice/group). (F) Tibiae 14 days after cortical bone defect surgery. Representative μCT images of tibial cortex and quantification of the newly formed bone volume (BV/TV). Scale bars: 1 mm (n = 5 mice/group). (G) H&E staining of defect site sections. Red boxes indicate the defect sites. Scale bars: 200 μm (n = 5 mice/group). (HJ). Representative images of defect site sections stained for Nestin and LepR. Quantification of Nestin+ cells (I) and LepR+ cells (J) in the defect sites. Scale bars: 100 μm (n = 5 mice/group). Dashed lines indicate the limit between periosteum and cortical bone. Data are presented as mean ± SEM. *P < 0.05; **P < 0.01. C, cortical bone; P, periosteum; NS, not significant as determined by 2-tailed Student t test.
Figure 6
Figure 6. PDGF-BB induces periostin expression via the PDGFR-β/PI3K/AKT/-CREB signaling pathway.
(A and B) Representative images of coronal tibia diaphyseal periosteum sections from Trap-cre Pdgfbfl/fl mice (A, left panels) and Ctsk–/– mice (B, left panels) with their control littermates stained for periostin. Quantification of the periostin+ cells in periosteum (no. cells/periosteum). Scale bars: 20 μm (n = 5 mice/group). (C) Nestin-GFP+PDGFR-α+CD45Ter119CD31 PDCs and PDC-derived osteoblasts were treated with 10 ng/ml PDGF-BB or vehicle. Western blot (left panel) and qRT-PCR analysis (right panel) of periostin expression level (n = 5 mice). (D and E) Western blot (left panel) and qRT-PCR analysis (right panel) of periostin expression level in PDCs. Cells were treated with 10 ng/ml PDGF-BB or vehicle for the indicated times (D) or with the indicated doses of PDGF-BB or vehicle for 6 hours (E) (n = 5 mice). (F) Western blot analysis of the phosphorylation of PDGFR-β, PI3K, AKT, and CREB (n = 5 mice). (G) Representative images stained for p-CREB and α-Tubulin in PDC-derived osteoblasts. Scale bars: 10 μm (n = 5 mice). (H) Western blot (left panel) and qRT-PCR analysis (right panel) of periostin expression levels in PDC-derived osteoblasts. Cells were treated with 10 ng/ml PDGF-BB or vehicle in the presence or absence of various inhibitors, as indicated (n = 5 mice). (I) p-CREB binding sites on periostin promoter. (J) ChIP analysis of p-CREB on specific periostin promoter regions in the cells with PDGF-BB or vehicle treatment (n = 3 mice). Data are presented as mean ± SEM. *P < 0.05; **P < 0.01; NS, not significant as determined by 2-tailed Student t test.
Figure 7
Figure 7. Knockout of Pdgfr-β in Nestin+ cells impairs recruitment of PDCs and periosteal bone formation in young mice.
(A and B) Representative images of coronal tibia diaphyseal periosteum sections from Nestin-creERT2 Pdgfr-βfl/fl mice and their control littermates (Pdgfr-βfl/fl) stained for TRAP and Nestin (A) and TRAP and LepR (B). (C and D) Quantification of Nestin+ cells (C) and LepR+ cells (D) in the inner layer of periosteum (no. cells/P.BS) and/or whole periosteum (no. cells/periosteum). Scale bars: 20 μm (n = 5 mice/group). (E and F) Percentage of Ki-67+ (E) or Brdu+ (F) cells in Nestin+ or LepR+ cells on periosteum (n = 5 mice/group). (G) Representative μCT images. Dashed line indicates the line between periosteum and cortical bone. Data are presented as mean ± SEM. *P < 0.05; **P < 0.01. Scale bars: 1 mm (n = 5 mice/group). 1 M, 1-month-old; 3 M, 3-month-old; C, cortical bone; P, periosteum; NS, not significant as determined by 2-tailed Student t test.
Figure 8
Figure 8. Knockout of Pdgfr-β in LepR+ cells impairs recruitment of PDCs and periosteal bone formation in adult mice.
(A and B) Representative images of coronal tibia diaphyseal periosteum sections from LepR-cre Pdgfr-βfl/fl mice and Pdgfr-βfl/fl mice stained for TRAP and Nestin (A) and TRAP and LepR (B). (C and D) Quantification of Nestin+ cells (C) and LepR+ cells (D) in the inner layer of periosteum (no. cells/P.BS) and/or whole periosteum (no. cells/periosteum). Scale bars: 20 μm (n = 5 mice/group). (E and F) Percentage of Ki-67+ (E) or Brdu+ (F) cells in Nestin+ or LepR+ cells on periosteum (n = 5 mice/group). (G) Representative μCT images. Scale bars: 1 mm (n = 5 mice/group). 1 M, 1-month-old; 3 M, 3-month-old. (H) Tibiae 14 days after cortical bone defect surgery. Representative μCT images of tibial cortex and quantification of newly formed bone volume (BV/TV). Scale bars: 1 mm (n = 5 mice/group). (I) H&E staining of defect site sections. Red boxes indicate the defect sites. Scale bars: 200 μm (n = 5 mice/group). (J and K) Representative images of defect site sections stained for Nestin and LepR. Quantification of Nestin+ cells (K, left panel) and LepR+ cells (K, right panel) in the defect sites. Scale bars: 100 μm (n = 5 mice/group). Dashed lines indicate the limit between periosteum and cortical bone. Data are presented as mean ± SEM. *P < 0.05; **P < 0.01. C, cortical bone; P, periosteum; NS, not significant as determined by 2-tailed Student t test.

Similar articles

Cited by

References

    1. Orwoll ES. Toward an expanded understanding of the role of the periosteum in skeletal health. J Bone Miner Res. 2003;18(6):949–954. doi: 10.1359/jbmr.2003.18.6.949. - DOI - PubMed
    1. Dimitriou R, Tsiridis E, Giannoudis PV. Current concepts of molecular aspects of bone healing. Injury. 2005;36(12):1392–1404. doi: 10.1016/j.injury.2005.07.019. - DOI - PubMed
    1. Jimenez-Andrade JM, et al. Capsaicin-sensitive sensory nerve fibers contribute to the generation and maintenance of skeletal fracture pain. Neuroscience. 2009;162(4):1244–1254. doi: 10.1016/j.neuroscience.2009.05.065. - DOI - PMC - PubMed
    1. Xie H, et al. PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis. Nat Med. 2014;20(11):1270–1278. doi: 10.1038/nm.3668. - DOI - PMC - PubMed
    1. Bonnet N, Gineyts E, Ammann P, Conway SJ, Garnero P, Ferrari S. Periostin deficiency increases bone damage and impairs injury response to fatigue loading in adult mice. PLoS One. 2013;8(10):e78347. doi: 10.1371/journal.pone.0078347. - DOI - PMC - PubMed

Publication types

Substances